Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Disopyramide 250mg modified-release tablets |
BNF code | 0203020G0AAACAC |
Virtual Therapeutic Moiety | Disopyramide |
Date identifier became valid | 30 Oct 2018 |
Previous product identifier | 318271004 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Disopyramide phosphate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 372844004 |
Strength value numerator | 250.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletmodified-release.oral |
Dose Form | |
Formulation | Modified-release tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Disopyramide 250mg modified-release tablets (Imported) | |
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd) | |
Virtual Medicinal Product Packs | |
Disopyramide 250mg modified-release tablets 20 tablet | |
Disopyramide 250mg modified-release tablets 40 tablet | |
Disopyramide 250mg modified-release tablets 56 tablet | |
Disopyramide 250mg modified-release tablets 60 tablet |
dm+d data retrieved from TRUD: release NHSBSA_10.2.0_20241021000001, imported on 21st October 2024 at 04:49:40.